10.05.05 Milan - Cosmo SpA, an Italian biotechnology R&D company, is preparing to close Euro25 million in Series A financing.After fundraising for several months, Vice Chairman Rolf Stahel said the financing will be led by an undisclosed...
more
10.05.05 Cremona/Evry - Italian and French scientists announced in April they have created a cloned horse, produced from the DNA of a thoroughbred Arabian gelding race champion.The foal, named Pieraz-Cryozootech-Stallion was created by...
more
10.05.05 Pisa - Private Italian Abiogen Pharma announced in April the start of a phase I-II clinical trial in Italy using ABIO 05/01 cells for the treatment of peritoneal carcinosis. The phase I-II trial on peritoneal cancer patients will...
more
06.03.05 Bresso - Newron Pharmaceuticals SpA, a research company focused on drug development for disorders of the Central Nervous System (CNS), has raised Euro30 million, of which Euro23 million have been secured at the end of February....
more
06.03.05 Parma/Ontario - Canadian GB Therapeutics Ltd. (GBt) entered into an agreement with Chiesi Farmaceutici SpA, headquartered in Parma, for an exclusive license to Chiesi's CHF1512 molecule which will result in an equity investment...
more
